NO163148B - PROCEDURE FOR PLANNING A SEALING SYSTEM ON A OFFSHOREBORE PLATFORM. - Google Patents

PROCEDURE FOR PLANNING A SEALING SYSTEM ON A OFFSHOREBORE PLATFORM. Download PDF

Info

Publication number
NO163148B
NO163148B NO822594A NO822594A NO163148B NO 163148 B NO163148 B NO 163148B NO 822594 A NO822594 A NO 822594A NO 822594 A NO822594 A NO 822594A NO 163148 B NO163148 B NO 163148B
Authority
NO
Norway
Prior art keywords
halogen
lower alkyl
alkyl
alkanoylamido
general formula
Prior art date
Application number
NO822594A
Other languages
Norwegian (no)
Other versions
NO822594L (en
NO163148C (en
Inventor
Michael Harry Collins
Original Assignee
Shell Int Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shell Int Research filed Critical Shell Int Research
Publication of NO822594L publication Critical patent/NO822594L/en
Publication of NO163148B publication Critical patent/NO163148B/en
Publication of NO163148C publication Critical patent/NO163148C/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B3/00Hulls characterised by their structure or component parts
    • B63B3/14Hull parts
    • B63B3/68Panellings; Linings, e.g. for insulating purposes
    • EFIXED CONSTRUCTIONS
    • E02HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02BHYDRAULIC ENGINEERING
    • E02B17/00Artificial islands mounted on piles or like supports, e.g. platforms on raisable legs or offshore constructions; Construction methods therefor
    • E02B17/0008Methods for grouting offshore structures; apparatus therefor
    • EFIXED CONSTRUCTIONS
    • E21EARTH OR ROCK DRILLING; MINING
    • E21BEARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B35/00Methods or apparatus for preventing or extinguishing fires

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Geology (AREA)
  • Mining & Mineral Resources (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Combustion & Propulsion (AREA)
  • Fluid Mechanics (AREA)
  • Ocean & Marine Engineering (AREA)
  • Environmental & Geological Engineering (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Building Environments (AREA)
  • Revetment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Fremgangsmåte ved fremstilling av substituerte 3-indolyl-eddiksyrer. Process for the production of substituted 3-indolyl acetic acids.

Foreliggende oppfinnelse angår en ny fremgangsmåte ved fremstilling av substituerte 3-indolyl-eddiksyrer med den generelle formel: The present invention relates to a new process for the production of substituted 3-indolyl acetic acids with the general formula:

hvor where

er fenyl, bifenylyl eller nafthyl som kan være substituert is phenyl, biphenylyl or naphthyl which may be substituted

med hydroxyl, lavere alkyl, lavere alkoxy, carbo-lavere alkoxy, lavere.alkanoyl, .lavere alkanoyloxy, fenyl, fenoxy, benzyl, benzyloxy, benzoyl, amino, mcno- eller di-lavere alkylamino, lavere alkanoylamido, N,N-di-(lavere alkyl)-earboxamido, .aminomethyl,' cyano, halogen, halogen-lavere alkyl, halogen-lavere alkoxy, halogen-lavere alkanoyl', mercapto, lavere elkylthio, halogen-lavere alkylthio, fenylthio, benzyl • thio, benzoylthio, lavere alkylsulfonyl, lavere alkylsulfinyl eller di-(lavere alkyl)-sulfamoyl, with hydroxyl, lower alkyl, lower alkoxy, carbo-lower alkoxy, lower.alkanoyl, .lower alkanoyloxy, phenyl, phenoxy, benzyl, benzyloxy, benzoyl, amino, mcno- or di-lower alkylamino, lower alkanoylamido, N,N-di -(lower alkyl)-earboxamido, .aminomethyl,' cyano, halogen, halogen-lower alkyl, halogen-lower alkoxy, halogen-lower alkanoyl', mercapto, lower alkylthio, halogen-lower alkylthio, phenylthio, benzyl • thio, benzoylthio, lower alkylsulfonyl, lower alkylsulfinyl or di-(lower alkyl)sulfamoyl,

PL-, er hydrogen eller lavere alkyl, og PL-, is hydrogen or lower alkyl, and

R,j er hydrogen, hydroxyl, lavere alkyl, lavere alkenyl, lavere alkoxy, amino, monolavere-alkylamino, di-lavere alkylsmino, bis-hydroxyethylamino, lavere alkanoylamido, aminomethyl, N-lavere alkyl-lavere alkanoylamido, di-lavere alkylaminomethyl, halogen, cyano, di-lavere alkylsulfamoyl, morfolino, N-methylpiperazinyl, N-pyrrolidyl eller N-åzacyclbpropyl., R,j is hydrogen, hydroxyl, lower alkyl, lower alkenyl, lower alkoxy, amino, monolower-alkylamino, di-lower alkylsmino, bis-hydroxyethylamino, lower alkanoylamido, aminomethyl, N-lower alkyl-lower alkanoylamido, di-lower alkylaminomethyl, halogen, cyano, di-lower alkylsulfamoyl, morpholino, N-methylpiperazinyl, N-pyrrolidyl or N-azacyclbpropyl.,

Et meget viktig' trekk ved fremgangsmåteforbindelsene er nærvær av en av de angitte aroylgrupper bundet til nitrogenatomet i 1-stillingeri x indolet. A very important feature of the process compounds is the presence of one of the indicated aroyl groups bound to the nitrogen atom in the 1-position of the indole.

I de foretrukne fremgangsmåteprodukter er lavere alkoxy, fortrinnsvis methoxy, eller di-lavere alkylamino, fortrinnsvis dimethylamino. In the preferred process products are lower alkoxy, preferably methoxy, or lower alkylamino, preferably dimethylamino.

Saltene av disse l-aroyl-3-indolyl-eddiksyrer kan erholdes ved at man behandler den frie syre med base under milde betingelser. På denne måte kan man fremstille alkalimetallsalter såsom natrium-og kalium-, aluminium- eller magnesium-salter, eller salter av jordalkalimetaller, eksempelvis barium- og calciumsalter. The salts of these 1-aroyl-3-indolyl-acetic acids can be obtained by treating the free acid with a base under mild conditions. In this way, one can prepare alkali metal salts such as sodium and potassium, aluminum or magnesium salts, or salts of alkaline earth metals, for example barium and calcium salts.

Det er kjent fra Journal of Organic Chemistry 2Q, side 1177, It is known from the Journal of Organic Chemistry 2Q, page 1177,

å redusere natrium-3-indolylglyoxylat katalytisk under dannelse av 70% natrium-3-indoiylglycolat og 10% 3-indolyleddiksyre. to catalytically reduce sodium 3-indolylglyoxylate to form 70% sodium 3-indolylglycolate and 10% 3-indolylacetic acid.

Det er videre fra belgisk patent nr. 615-395 kjent at 1-acyl-3-indolyl-eddiksyrebenzylestere kan hydrogenolyseres uten angrep på 1-acylgruppen. It is further known from Belgian patent no. 615-395 that 1-acyl-3-indolyl-acetic acid benzyl esters can be hydrogenolysed without attack on the 1-acyl group.

Det kan imidlertid ut fra disse reaksjoner ikke trekkes noen slutninger angående reaksjonsbetingelsene som er nodvendige for å gjennomfore trinn. 1 av foreliggende fremgangsmåte. However, no conclusions can be drawn from these reactions regarding the reaction conditions that are necessary to carry out steps. 1 of the present method.

Fremgangsmåteforbindelsene som er omtalt ovenfor, har i hoy grad anti-inflammatorisk aktivitet og kan brukes til å hindre og hemme dannelse av granulomavev. Enkelte av dem har denne aktivitet i sterk grad og er av verdi ved behandling av arthritis og dermato-logiske sykdommer og lignende tilstander som reagerer på behandling med anti-inflammatoriske midler. Dertil har fremgangsmåteproduktene i betydelig grad antipyretisk aktivitet. For disse formål blir de normalt anvendt oralt i form av tabletter eller kapsler, og den optimale dose avhenger selvsagt av den spesielle forbindelse som brukes og av infeksjonens art og grad. Skjont de optimale mengder av disse forbindelser vil avhenge av den forbindelse som anvendes, The method compounds discussed above have a high degree of anti-inflammatory activity and can be used to prevent and inhibit the formation of granuloma tissue. Some of them have this activity to a strong degree and are of value in the treatment of arthritis and dermatological diseases and similar conditions that respond to treatment with anti-inflammatory agents. In addition, the process products have antipyretic activity to a considerable extent. For these purposes, they are normally used orally in the form of tablets or capsules, and the optimal dose obviously depends on the particular compound used and on the nature and degree of the infection. Although the optimal amounts of these compounds will depend on the compound used,

og av den spesielle sykdomstilstand som skal behandles, kan de foretrukne forbindelser oralt brukes i mengder innen området 1,0 - 200 mg pr. dag i tilfelle av arthritis, avhengig av den spesielle forbind-elses aktivitet og pasientens reaksjonsfolsomhet. and of the particular disease state to be treated, the preferred compounds can be orally used in amounts within the range of 1.0 - 200 mg per day in the case of arthritis, depending on the activity of the particular compound and the patient's responsiveness.

I henhold til.oppfinnelsen fremstilles forbindelsene av formel I ved at en forbindelse med den generelle formel: hvor R-^ og R^ er som ovenfor angitt, og R'^ er R^ eller nitro, hydrogeneres ved et trykk på ca. lh kg/cm^, i nærvær av en palladium-katalysator i et inert opplosningsmiddel som dioxan, og at den dannede forbindelse med den generelle formel: According to the invention, the compounds of formula I are prepared by hydrogenating a compound of the general formula: where R-^ and R^ are as indicated above, and R'^ is R^ or nitro, at a pressure of approx. lh kg/cm^, in the presence of a palladium catalyst in an inert solvent such as dioxane, and that it formed a compound of the general formula:

hvor R-p Rp og R ^ er som ovenfor angitt, oppvarmes i et inert opplosningsmiddel i nærvær av en katalytisk virkende mengde av en sterk syre, og at den således dannede syre, om onskes, overfores til et salt derav på i og for seg kjent vis. where R-p Rp and R ^ are as indicated above, is heated in an inert solvent in the presence of a catalytically effective amount of a strong acid, and that the acid thus formed, if desired, is transferred to a salt thereof in a manner known per se .

Foretrukne forbindelser fåes ved å gå ut fra en forbindelse Preferred connections are obtained by starting from a connection

av formel II hvor R^ er p-klorfenyl, R^ er methyl og R^ er methoxy eller dimethylamino. of formula II where R^ is p-chlorophenyl, R^ is methyl and R^ is methoxy or dimethylamino.

De i det foreliggende beskrevne l-aroyl-3-indolyl-eddiksyrer fremstilles ved at en t-butylester i det annet trinn omdannes til den frie syre under passende reaksjonsbetingelser. Man har observert at 1-aroyl-substituenten lett hydrolyseres under betingelser som vanligvis brukes ved forsåpning av en ester til den frie syre. Av denne grunn må der utvises forsiktighet ved omdannelsen av 1-aroyl-3-indolyl-eddiksyre-esteren til de tilsvarende frie syrer. The 1-aroyl-3-indolyl acetic acids described herein are prepared by converting a t-butyl ester in the second step to the free acid under suitable reaction conditions. It has been observed that the 1-aroyl substituent is readily hydrolyzed under conditions commonly used in the saponification of an ester to the free acid. For this reason, care must be taken in the conversion of the 1-aroyl-3-indolyl-acetic acid ester to the corresponding free acids.

Den anti-inflammatoriske virkning av fremgangsmåteforbindelsene fremgår av en granulomahémmende prove som er utfort som folger: The anti-inflammatory effect of the process compounds is evident from a granuloma-inhibiting test which is carried out as follows:

Proven er én modifikasjon av den som er beskrevet av Meier The proof is one modification of the one described by Meier

og medarb. (Experientia 6 1950, *+69) • Den består hovedsakelig i implantering av steriliserte bomullspellets på rotter, fjernelse av pelletene efter 7 dager (systemprove) eller 5.dager (lokalprove), og bestemmelse av oknirigen av torrvekt av hver pellet. and collaborators (Experientia 6 1950, *+69) • It consists mainly in the implantation of sterilized cotton pellets on rats, the removal of the pellets after 7 days (system sample) or 5 days (local sample), and determination of the oknirigen of dry weight of each pellet.

Den: opprinnelige vekt av pelletene varierte fra forsok til forsok,.men innen et og samme forsok var alle innen en toleranse på + 1 mg. To pellets ble inrifort i hvert dyr., en på hver side av bukhulen. Når lokalvirkningen av en forbindelse skulle studeres, ble forbindelsen anbragt på en pellet i et medium inneholdende fuktemiddel, mens mediet alene ble brukt på den annen pellet, slik at hvert dyr var sin egen kontroll. Ved systemprover utgjorde den gjennomsnittlige granuloma-torrvekt av de to prover i hvert dyr det individuelle resultat. Proveforbindelsene ble gitt oralt.en gang daglig ved innforing i maven med sonde. The: initial weight of the pellets varied from trial to trial, but within one and the same trial all were within a tolerance of + 1 mg. Two pellets were injected into each animal, one on each side of the abdominal cavity. When the local effect of a compound was to be studied, the compound was placed on a pellet in a medium containing a wetting agent, while the medium alone was used on the other pellet, so that each animal was its own control. In the case of systemic samples, the average granuloma dry weight of the two samples in each animal constituted the individual result. The test compounds were given orally once a day by insertion into the stomach with a probe.

Ved alle forsok ble anvendt Holtzman-hanrotter over legemsvekt ca. 125 - 175 g. Aktiviteten ble uttrykt ved tallene 1 - h med folg-ende betydning: In all experiments, male Holtzman rats over a body weight of approx. 125 - 175 g. The activity was expressed by the numbers 1 - h with the following meaning:

1 omtrent så god som acetylsalicylsyre 1 about as good as acetylsalicylic acid

2 " " " " fenylbutazon 2 " " " " phenylbutazone

3 10 - 25 ganger så god som fenylbutazon 3 10 - 25 times as good as phenylbutazone

h 50 -100 " " " " " h 50 -100 " " " " "

De anvendte forbindelser og deres aktivitet fremgår av folg-ende tabell. The compounds used and their activity are shown in the following table.

Eksempel Example

Trinn 1 Step 1

^-,38 g t-butyl-l-p-klorbenzoyl-2-methyl-5-me'thoxy-3-indolyl-glyoxylat opplbses i 50 ml torr dioxan og hydrogeneres ved 30°C under et trykk på lh kg/cm 2 under anvendelse av 1,0 g palladium-p<å>o-carbon-katalysator med 10$ palladium. Hydrogeneringen er fullfort efter 8 tiimer. ^-.38 g of t-butyl-1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolyl-glyoxylate are dissolved in 50 ml of dry dioxane and hydrogenated at 30°C under a pressure of lh kg/cm 2 under using 1.0 g of palladium p<å>o carbon catalyst with 10% palladium. The hydrogenation is complete after 8 hours.

Katalysatoren frafiltreres derpå og filtratet inndampes, hvor-ved man.får et oljeaktig stoff. Dette residuum omkrystalliseres fra 25 ml hexan. Man får t-butyl-l-(p-klorbenzoyl)-2-methyl-5-methoxy-3-indolyl-acetat. The catalyst is then filtered off and the filtrate is evaporated, whereby an oily substance is obtained. This residue is recrystallized from 25 ml of hexane. t-Butyl-1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl-acetate is obtained.

Trinn 2 Step 2

300 ml p-toluensulfonsyremonohydrat (1,0 g) tilsettes til benzen som inneholder t-butyl-l-(p-klorbenzoyl)-2-methyl-5-methoxy-3-indolylacetat (0,03 mol), og den erholdte blanding oppvarmes under tilbakelopskjoling og omroring i nitrogenatmosfære i ^0 minutter. Herunder utvikles der 665 ml isobutylen (teoretisk 672 ml ). Reak-sjonsblandingen fortynnes med 200 ml benzen ved en temperatur på 300 ml of p-toluenesulfonic acid monohydrate (1.0 g) is added to benzene containing t-butyl-1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl acetate (0.03 mol), and the resulting mixture heated under reflux and stirring in a nitrogen atmosphere for ^0 minutes. Below this, 665 ml of isobutylene is developed (theoretically 672 ml). The reaction mixture is diluted with 200 ml of benzene at a temperature of

55 - 60°C og vaskes med varmt vann ved 60 - 65°C til en pH-verdi 55 - 60°C and washed with hot water at 60 - 65°C to a pH value

av k - 5. Den varme opplosning i benzen (temperatur 60 - 65°C) befries for vann med natriumsulfat og avfarves ved tilsetning av 1,0 g Darco G-60. Oppløsningen filtreres derpå i varm tilstand og inndampes til et volum på ca. 50 - 75 ml. Derefter avkjoles bland-ingen til 10°C, og man lar den henstå i h - 5' timer. Den herved erholdte urene l-(p-klorbenzoyl)-2-methyl-5-methoxy-3-indolyleddiksyre frafiltreres, vaskes to ganger med 5 ml av en blanding av benzen og .petrolether (1:1), derpå to ganger med 10 ml petrolether og torres i vakuum ved 25°C. Produktets vekt er 9,7 g, (benzensolvat) sm.p. 110 - 115°C. of k - 5. The hot solution in benzene (temperature 60 - 65°C) is freed from water with sodium sulfate and decolorized by adding 1.0 g of Darco G-60. The solution is then filtered while hot and evaporated to a volume of approx. 50 - 75 ml. The mixture is then cooled to 10°C, and left to stand for 1-5 hours. The impure 1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid thus obtained is filtered off, washed twice with 5 ml of a mixture of benzene and petroleum ether (1:1), then twice with 10 ml petroleum ether and dried in vacuum at 25°C. The weight of the product is 9.7 g, (benzene solvate) m.p. 110 - 115°C.

9,7 g av dette råprodukt opploses i 38,8 ml t-butanol ved 70°C. Den erholdte opplosning filtreres og tilsettes i varm tilstand (60 - 70°C) 38,8 ml cyclohexan. Oppløsningen avkjoles til 10°C, hvorpå man lar den henstå i 1 time. Produktet frafiltreres så, vaskes to ganger med h ml av en kold blanding av t-butanol og cyclohexan (1:1) og derpå to ganger med 10 ml petrolether. Det torres derpå i vakuum ved 80°C i nitrogenatmosfære. Det erholdte produkt er 1-(p-klorbenzoyl)-2-methyl-5-methoxy-3-indolyl-eddiksyre med smeltep\inkt 153 - 154°C. 9.7 g of this crude product are dissolved in 38.8 ml of t-butanol at 70°C. The solution obtained is filtered and 38.8 ml of cyclohexane are added in a warm state (60 - 70°C). The solution is cooled to 10°C, after which it is allowed to stand for 1 hour. The product is then filtered off, washed twice with 10 ml of a cold mixture of t-butanol and cyclohexane (1:1) and then twice with 10 ml of petroleum ether. It is then dried in a vacuum at 80°C in a nitrogen atmosphere. The product obtained is 1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl-acetic acid with a melting point of 153 - 154°C.

Claims (1)

Fremgangsmåte ved fremstilling av substituerte 3-indolyl-eddiksyrer med den generelle formel:Procedure for the production of substituted 3-indolyl acetic acids with the general formula: hvor R-^ er fenyl, bifenylyl eller nafthyl som kan være substituert med hydroxyl, lavere alkyl, lavere alkoxy, carbo-lavere alkoxy, lavere alkanoyl, lavere alkanoyloxy,■fenyl, fenoxy, benzyl, benzyloxy, benzoyl, amino, mono- eller di-lavere alkylamino, lavere alkanoylamido, N,N-di-(lavere alkyl)-carboxamido, aminomethyl,where R-^ is phenyl, biphenylyl or naphthyl which may be substituted with hydroxyl, lower alkyl, lower alkoxy, carbo-lower alkoxy, lower alkanoyl, lower alkanoyloxy, ■phenyl, phenoxy, benzyl, benzyloxy, benzoyl, amino, mono- or di-lower alkylamino, lower alkanoylamido, N,N-di-(lower alkyl)-carboxamido, aminomethyl, cyano, halogen, halogen-lavere alkyl, halogen-lavere alkoxy, halogen-lavere alkanoyl, mercapto, lavere alkylthio, halogen-lavere alkylthio, fenylthio, benzylthio, benzoylthio, lavere alkylsulfonyl,. lavere alkylsulfinyl eller di-(lavere alkyl)-sulfamoyl,cyano, halogen, halogen-lower alkyl, halogen-lower alkoxy, halogen-lower alkanoyl, mercapto, lower alkylthio, halogen-lower alkylthio, phenylthio, benzylthio, benzoylthio, lower alkylsulfonyl,. lower alkylsulfinyl or di-(lower alkyl)-sulfamoyl, R2 er hydrogen eller lavere alkyl, og R^ er hydrogen, hydroxyl, lavere alkyl, lavere alkenyl, lavere alkoxy, amino, monolaverealkylamino, di-lavere'alkylamino, bis-hydroxyethy]ainino, lavere alkanoylamido, aminomethyl, N-lavere alkyl-lavere alkanoylamido, di-lavere alkylaminomethyl, halogen, cyano, di-lavere alkylsulfamoyl, morfolino, N-methylpiperazinyl, N-pyrrolidyl eller N-azacyclopropyl,R 2 is hydrogen or lower alkyl, and R 2 is hydrogen, hydroxyl, lower alkyl, lower alkenyl, lower alkoxy, amino, monolower alkylamino, di-lower alkylamino, bis-hydroxyethy]ainino, lower alkanoylamido, aminomethyl, N-lower alkyl- lower alkanoylamido, di-lower alkylaminomethyl, halogen, cyano, di-lower alkylsulfamoyl, morpholino, N-methylpiperazinyl, N-pyrrolidyl or N-azacyclopropyl, samt salter derav,as well as salts thereof, karakterisert ved at en forbindelse med den generelle formel:characterized in that a compound with the general formula: hvor R^ og R2 er som ovenfor angitt, og R'^ er R^ eller nitro, hydrogeneres ved et trykk på ca. 1^ kg/cm^, i nærvær av en palla-diumkatalysator i et inert opplosningsmiddel sem dioxan, og at den dannede forbindelse med den generelle formel:where R 1 and R 2 are as indicated above, and R 1 is R 2 or nitro, is hydrogenated at a pressure of approx. 1^ kg/cm^, in the presence of a palladium catalyst in an inert solvent such as dioxane, and that it formed a compound with the general formula: hvor R^, B.^ og R^ er som ovenfor angitt, oppvarmes i et inert opplosningsmiddel i nærvær av en katalytisk virkende mengde av en sterk syre, og at den således dannede syre, om onskes, overfores til et salt derav på i og for seg kjent vis.where R^, B.^ and R^ are as indicated above, is heated in an inert solvent in the presence of a catalytically effective amount of a strong acid, and that the acid thus formed is, if desired, transferred to a salt thereof of i and familiar way.
NO822594A 1981-07-30 1982-07-28 PROCEDURE FOR PLANNING A SEALING SYSTEM ON A OFFSHOREBORE PLATFORM. NO163148C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08123327A GB2103482B (en) 1981-07-30 1981-07-30 A sealing system for use on an offshore platform

Publications (3)

Publication Number Publication Date
NO822594L NO822594L (en) 1983-01-31
NO163148B true NO163148B (en) 1990-01-02
NO163148C NO163148C (en) 1990-04-11

Family

ID=10523569

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822594A NO163148C (en) 1981-07-30 1982-07-28 PROCEDURE FOR PLANNING A SEALING SYSTEM ON A OFFSHOREBORE PLATFORM.

Country Status (5)

Country Link
CA (1) CA1178813A (en)
DK (1) DK161983C (en)
GB (1) GB2103482B (en)
NL (1) NL8202795A (en)
NO (1) NO163148C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10422456B2 (en) 2012-12-07 2019-09-24 Apl Technology As Tube connector for detachably connecting two connector parts for gas-tight connecting of riser tubes to vessels

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2802792A (en) * 1992-04-02 1993-11-08 Akro-Fireguard Products, Inc. Aircraft fuselage flame barrier

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10422456B2 (en) 2012-12-07 2019-09-24 Apl Technology As Tube connector for detachably connecting two connector parts for gas-tight connecting of riser tubes to vessels

Also Published As

Publication number Publication date
NO822594L (en) 1983-01-31
DK161983B (en) 1991-09-02
CA1178813A (en) 1984-12-04
DK161983C (en) 1992-02-17
NL8202795A (en) 1983-02-16
GB2103482A (en) 1983-02-23
GB2103482B (en) 1985-05-09
DK336582A (en) 1983-01-31
NO163148C (en) 1990-04-11

Similar Documents

Publication Publication Date Title
US3654349A (en) Substituted indenyl acetic acids
US4342776A (en) 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
US5696159A (en) Lactone compounds for treating patients with precancerous lesions
NO162189B (en) ANALOGY PROCEDURE TE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOPYRIDINES.
US4309442A (en) Method for controlling fertility in mammals
NO883146L (en) ANTI-INFLAMMATORALLY ACTIVE ARYLET DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION.
US4820827A (en) 2,3-diaryl-5-bromothiophene compounds of use for the treatment of inflammaton and dysmenorrhea
US20020107248A1 (en) Method for treating patients with neoplasia by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereof
EP0219961B1 (en) Irreversible dopamine-b-hydroxylase inhibitors
US4069337A (en) 2-substituted-indole-1-lower-alkanecarboxamides having anti-secretory or anti-ulcer activity
IE52444B1 (en) New derivatives of phenyl aliphatic carboxylic acids,their preparation,their use as medicaments and compositions containing them
NO163148B (en) PROCEDURE FOR PLANNING A SEALING SYSTEM ON A OFFSHOREBORE PLATFORM.
NO143735B (en) PULLERTANORDNING.
JPS63253070A (en) Inidazole derivative
CH658053A5 (en) DERIVATIVE OF PYRAZOLO (1,5-A) PYRIDINE ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
IE50767B1 (en) 5-amino-tetrazole derivatives of retinoic acids,their preparation,and pharmaceutical formulations containing these derivatives
DE2535799C3 (en) N&#39;- [1 - (p-Chlorobenzoyl) -5-methoxy-2-methyl-3indolyl-acetoxy-alkyl] -N- (N-benzoyl-N&#39;JS&#39;-di-n-propyl-DL-isoglutaminyloxy-alkyD-piperazine and preparations containing inflammation and joint affection inhibiting preparations
US4219668A (en) 4-Hydroxy,4-biphenylbutyric acid
JP3056245B2 (en) Phenyl sulfone derivative
US4867737A (en) Derivatives of 4-phenyl-4-oxo-2-butenoic acid their preparation process, their use as medicaments and compositions containing them
NO121838B (en)
US4156016A (en) Indole compounds and process for their preparation
US4110465A (en) 7-amino and 7-alkanoylamino 2-oxo-3-phenylindolines
FR2499572A1 (en) 17,18-DESHYDROAPOVINCAMINOL 3 &#39;, 4&#39;, 5&#39;-TRIMETHOXYBENZOATE AND ITS SALTS FORMED BY ADDITION WITH ACIDS, THEIR THERAPEUTIC USES IN THE TREATMENT OF DISEASES ASSOCIATED WITH CELL PROLIFERATION, METHODS FOR THEIR PREPARATION AND INTERMEDIATE PRODUCTS OF THEM PREPARATION
DE3239220C2 (en)